Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Diabetes Care ; 47(9): 1622-1629, 2024 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-38940851

RESUMO

OBJECTIVE: Women with a history of gestational diabetes mellitus (GDM) are at increased risk of developing type 2 diabetes (T2D). It remains unclear whether genetic information improves prediction of incident T2D in these women. RESEARCH DESIGN AND METHODS: Using five independent cohorts representing four different ancestries (n = 1,895), we investigated whether a genome-wide T2D polygenic risk score (PRS) is associated with increased risk of incident T2D. We also calculated the area under the receiver operating characteristics curve (AUROC) and continuous net reclassification improvement (NRI) following the incorporation of T2D PRS into clinical risk models to assess the diagnostic utility. RESULTS: Among 1,895 women with previous history of GDM, 363 (19.2%) developed T2D in a range of 2 to 30 years. T2D PRS was higher in those who developed T2D (-0.08 vs. 0.31, P = 2.3 × 10-11) and was associated with an increased risk of incident T2D (odds ratio 1.52 per 1-SD increase, 95% CI 1.05-2.21, P = 0.03). In a model that includes age, family history of diabetes, systolic blood pressure, and BMI, the incorporation of PRS led to an increase in AUROC for T2D from 0.71 to 0.74 and an intermediate improvement of NRI (0.32, 95% CI 0.15-0.49, P = 3.0 × 10-4). Although there was variation, a similar trend was observed across study cohorts. CONCLUSIONS: In cohorts of GDM women with diverse ancestry, T2D PRS was significantly associated with future development of T2D. A significant but small improvement was observed in AUROC when T2D PRS was integrated into clinical risk models to predict incident T2D.


Assuntos
Diabetes Mellitus Tipo 2 , Diabetes Gestacional , Estudo de Associação Genômica Ampla , Humanos , Feminino , Diabetes Gestacional/genética , Diabetes Gestacional/epidemiologia , Diabetes Mellitus Tipo 2/genética , Diabetes Mellitus Tipo 2/epidemiologia , Gravidez , Adulto , Pessoa de Meia-Idade , Fatores de Risco , Herança Multifatorial/genética , Estratificação de Risco Genético
2.
Materials (Basel) ; 14(2)2021 Jan 13.
Artigo em Inglês | MEDLINE | ID: mdl-33451029

RESUMO

Lead(II)-acetate (Pb(Ac)2) is a promising lead source for the preparation of organolead trihalide perovskite materials, which avoids the use of inconvenient anti-solvent treatment. In this study, we investigated the effect of cesium doping on the performance of Pb(Ac)2-based perovskite solar cells (PSCs). We demonstrate that the quality of the CH3NH3PbI3 perovskite film was improved with increased crystallinity and reduced pinholes by doping the perovskite with 5 mol% cesium. As a result, the power conversion efficiency (PCE) of the PSCs was improved from 14.1% to 15.57% (on average), which was mainly induced by the significant enhancements in short-circuit current density and fill factor. A PCE of 18.02% was achieved for the champion device of cesium-doped Pb(Ac)2-based PSCs with negligible hysteresis and a stable output. Our results indicate that cesium doping is an effective approach for improving the performance of Pb(Ac)2-based PSCs.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA